E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2008 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
12/19/08MedPlus® ChartMaxx® Receives 2008 ‘Best in KLAS’ Ranking for Healthcare Document Management and Imaging Software
Healthcare Professionals Rank ChartMaxx Number One DMI Solution for Fifth Time Cincinnati, OH – December 19, 2008 – Healthcare professionals have chosen MedPlus’ ChartMaxx® enterprise-wide electronic patient record system as the top healthcare Document Management and Imaging (DMI) software product, according to the 2008 Top 20 Best in KLAS Awards: Software & Professional Services report, an independent ranking based on customer feedback of top healthcare information technology (HIT) vendor... 
Printer Friendly Version
12/18/08Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on January 26, 2009, to shareholders of record on January 9, 2009. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, info... 
Printer Friendly Version
12/02/08Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference
MADISON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Piper Jaffray Healthcare Conference in New York City today, December 2, 2008. The Quest Diagnostics presentation is scheduled to begin at 4:00 p.m. Eastern Time. During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%,... 
Printer Friendly Version
11/17/08Quest Diagnostics' Laboratory in India Accredited by Two Leading Laboratory Accrediting Organizations
- Less than one tenth of one percent of labs in India are CAP and NABL accredited - Quest Diagnostics' laboratory also becomes one of only five labs in India to achieve NGSP certification for Hemoglobin A1c testing for diabetes MADISON, N.J. and GURGAON, India, Nov. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it... 
Printer Friendly Version
11/10/08Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference
MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Credit Suisse Healthcare Conference on Wednesday, November 12, 2008. The Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%, operat... 
Printer Friendly Version
10/25/08Rotavirus Infections Decline More than 70 Percent in Children in U.S.
Quest Diagnostics Health Trends(TM) Report shows declines vary widely by state MADISON, N.J., Oct. 25 /PRNewswire-FirstCall/ -- The largest study of rotavirus laboratory data developed since an oral rotavirus vaccine was introduced in the U.S. in early 2006 shows that cases of rotavirus infection have decreased significantly, suggesting the vaccine is preventing infection in infants and young children. The latest Quest Diagnostics Health Trends(TM) Report also provides evidence fo... 
Printer Friendly Version
10/21/08Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
Total revenues of $1.8 billion, up 3.4% Adjusted diluted earnings per share of $0.86, up 12% Cash flow from operations improved to $329 million 2008 adjusted EPS guidance increased to $3.17 - $3.22 per diluted share Agreement in principle reached regarding previously disclosed NID-related matter MADISON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- , 2008-- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, informa... 
Printer Friendly Version
10/08/08Quest Diagnostics to Release Third Quarter 2008 Financial Results
MADISON, N.J., Oct. 8 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its third-quarter 2008 results will be made public on Tuesday, October 21, before the market opens, and that it will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast availa... 
Printer Friendly Version
09/23/08Quest Diagnostics to Speak at the 2008 UBS Global Life Sciences Conference
MADISON, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 2008 UBS Global Life Sciences Conference on Wednesday, September 24, 2008. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors ... 
Printer Friendly Version
09/10/08Quest Diagnostics Again Named to Dow Jones Sustainability World and North American Indexes
2008 marks fifth year on World Index MADISON, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it was again selected to be part of the Dow Jones Sustainability (DJSI) World and North American Indexes. The company is in its fifth year on the World Index, first added in 2004, and has appeared on the North American Index since 2005. ... 
Printer Friendly Version
08/05/08Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on October 20, 2008, to shareholders of record on October 3, 2008. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, infor... 
Printer Friendly Version
07/22/08Quest Diagnostics Reports Strong Revenue and Earnings Growth in Second Quarter 2008
- Total revenues of $1.8 billion, up 12%; - Diluted earnings of $0.83 per share, up 14%; - Cash flow improved to $213 million; - 2008 EPS guidance midpoint increased, new range $3.10 to $3.20 per diluted share. MADISON, N.J., July 22 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the second quarter ended June 30, 2008, income from con... 
Printer Friendly Version
07/10/08Quest Diagnostics to Release Second Quarter 2008 Financial Results
MADISON, N.J., July 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its second-quarter 2008 results will be made public on Tuesday, July 22, before the market opens, and that it will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webc... 
Printer Friendly Version
06/23/08Quest Diagnostics to Speak at the Jefferies 2nd Annual Healthcare Conference
MADISON, N.J., June 23 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies Healthcare Conference on Tuesday, June 24, 2008. The Quest Diagnostics presentation is scheduled to begin at 9:00a.m. Eastern Time. The presentation will be webcast live during the conference and will be available to registered investors on the following si... 
Printer Friendly Version
06/20/08Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program
MADISON, N.J., June 20 /PRNewswire-FirstCall/ -- Women in Ireland will soon be able to take advantage of diagnostic testing services provided by Quest Diagnostics Incorporated (NYSE: DGX), the world's leader in cervical-cancer screening services. Through a contract with the Irish National Cancer Screening Service (NCSS), Quest Diagnostics will provide quality-assured screening services intended to improve medical outcomes and reduce anxiety wait time for women ages 25 to 60 who partici... 
Printer Friendly Version
06/18/08HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- HemoCue(R) AB, a global point-of-care diagnostic test manufacturer and wholly owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening for, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the U.S. Food and Drug Administration (FDA). With the FDA CLIA waiver, non-laboratory trained physicians and... 
Printer Friendly Version
06/03/08Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced results of a study that demonstrates that a novel diagnostic testing technique it has developed is the first to provide direct, accurate and reproducible physical measurement of both the size and concentration of a broad range of lipoproteins in blood plasma. Results of the study were published in the May 29, 2008, online edition of Clinical Chemistry. "Our data suggest that ... 
Printer Friendly Version
05/21/08Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 18, 2008, to shareholders of record on July 3, 2008. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and ser... 
Printer Friendly Version
05/20/08Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds
SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- An interim analysis of a study presented today at the 39th Annual Digestive Disease Week (DDW) Conference found that, among patients at increased risk for colorectal cancer who completed an annual fecal immunochemical (FIT) test, detection of cancerous lesions occurred an average of 26.5 months earlier than would have occurred during the three- or five-year study-required colonoscopy. Detection of precancerous lesions in this group occurred 1... 
Printer Friendly Version
05/19/08Quest Diagnostics and Google Empower Patients and Physicians to Share Diagnostic Test Results Online With Launch of Google Health
MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Patients and physicians have a new way to share diagnostic laboratory data online, thanks to Quest Diagnostics and Google Health, a product launched today by Google. More than 100,000 physicians in the U.S. who use Quest Diagnostics' family of Care360(TM) connectivity products will be able to securely provide diagnostic data with a brief explanation of test results to a patient's Google Health Account, where a patient can maintain medica... 
Printer Friendly Version
05/13/08Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles'
Company's "Biggest Loser" Bill Germanakos to Deliver NBGH Keynote Address MADISON, N.J., May 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that the National Business Group on Health (NBGH), an association of more than 300 large U.S. employers, has presented its 2008 Best Employers for Healthy Lifestyles Gold Award to the company for its HealthyQuest employee wellness progr... 
Printer Friendly Version
05/12/08Quest Diagnostics Announces Annual Shareholder's Meeting Webcast
MADISON, N.J., May 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, will conduct its annual meeting of shareholders on Friday, May 16th at 10:30 am ET. An audio webcast will be accessible through the Investor Relations section of the company Web site at www.questdiagnostics.com/investor . For those unable to listen to the live broadcast, a replay will be available on the Web site beginni... 
Printer Friendly Version
05/08/08Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
- New test provides laboratory-quality results in physician's office - MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Enterix Inc., a wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced the availability of the InSure(R) Quik F I T(TM) fecal immunochemical test, a point-of-care version of the company's lab-based InSure(R) FIT(TM) test, that provides physicians with the sensitivity and specificity of the laboratory-based InSure FIT test. The av... 
Printer Friendly Version
04/21/08Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
- 2008 Outlook Reaffirmed - MADISON, N.J., April 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2008, income from continuing operations was $141 million, or $0.72 per diluted share, compared to $108 million, or $0.55 per diluted share, in the first quarter of 2007. Included in the results for the first qu... 
Printer Friendly Version
04/07/08Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
MADISON, N.J., April 7, 2008 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced today that it will make public its first-quarter 2008 results on Monday, April 21, before the market opens, and that it will conduct it's first quarter investor conference call at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Quest Diagnostics... 
Printer Friendly Version
03/31/08Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
'Do You Have the Guts?' aims to reach five million in five yearsMADISON, N.J., March 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing information and services, today announced the launch of a novel campaign designed to help increase compliance with take-home colorectal screening tests. Titled "It's Time to Challenge Colon Cancer: Do You Have the Guts?," the campaign aims to break down ... 
Printer Friendly Version
03/14/08Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference
MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Wednesday, March 19, 2008, at The Loews Miami Beach Hotel, Miami, Florida. The Quest Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern Time. The presentation will be webcast live duri... 
Printer Friendly Version
03/14/08Quest Diagnostics to Speak at Cowen and Company 28th Annual Health Care Conference
MADISON, N.J., March 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Cowen and Company Twenty Eighth Annual Health Care Conference on Tuesday, March 18, 2008, at the Marriott Copley Place, Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:45 a.m. Eastern Time. The presentation will be webcast live ... 
Printer Friendly Version
03/12/08Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- The percentage of positive tests for methamphetamine among U.S. job applicants and workers in the general U.S. workforce dropped more than 22 percent between 2006 and 2007. These findings, from the Quest Diagnostics Drug Testing Index(R), reflect the reversal of an upward trend in use of the drug by more than 73 percent from 2002 to 2004. These data were released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading... 
Printer Friendly Version
03/12/08Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds
MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- Diabetes and hypertension are the two leading risk factors for chronic kidney disease (CKD), responsible for up to two-thirds of cases. Yet a new study that will be presented at a National Kidney Foundation Spring Clinical Meeting next month indicates there is wide discrepancy in diagnostic testing for kidney disease among patients with these conditions, with patients with high blood pressure (hypertension) tested at half the rate as th... 
Printer Friendly Version
03/05/08Quest Diagnostics Named to FORTUNE Magazine's America's Most Admired Companies List
Only diagnostic testing company in rankingMADISON, N.J., March 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that it has been selected by FORTUNE magazine to the 2008 list of America's Most Admired Companies. Quest Diagnostics was ranked third among four companies in the "Health Care" category of "pharmacy and other services." 2008 marks the first year the company has been named to the list. "Our ranking as one of the m... 
Printer Friendly Version
02/28/08Quest Diagnostics to Collaborate with Google on New Health Offering
Partnership will provide patients electronic access to their diagnostic laboratory data MADISON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Patients nationwide may soon have easy and secure access to their own medical diagnostic laboratory records as a result of a new collaboration between Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and Google, the world's leading Internet sear... 
Printer Friendly Version
02/25/08MedPlus Technology Driving Three New York Health Information Exchanges
Clinical Portal & Data Exchange Engine Implementations Begin for HEAL 1 Grant Recipients CINCINNATI, Feb. 25 /PRNewswire/ -- MedPlus(R), the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has begun installations of its Clinical Portal & Data Exchange Engine for three health information exchanges (HIE) qualified for HEAL NY (Healthcare Efficiency and Affordability Law for New Yorkers) ... 
Printer Friendly Version
02/21/08Quest Diagnostics Reports Fourth Quarter and Full Year Results
Company Provides 2008 Guidance MADISON, N.J., Feb. 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2007, income from continuing operations was $154 million, or $0.79 per diluted share, compared to $151 million, or $0.77 per diluted share, in the fourth quarter of 2006. The fourth quarter of 2007 include... 
Printer Friendly Version
02/20/08Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India
MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE:DGX), the leading provider of diagnostic testing, information and services, today announced that its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd. has entered into a long-term agreement to provide health assessment services, including diagnostic laboratory testing, for Birla Sun Life Insurance Company Limited (Birla Sun Life), a joint venture between The Aditya Birla Group, one of the larg... 
Printer Friendly Version
02/19/08Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
Company Licenses Septin-9 DNA Methylation Biomarker from Epigenomics MADISON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, today announced that it has licensed rights to uses of the Septin 9 DNA methylation biomarker from Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, to develop a molecular-based laboratory test that can help physic... 
Printer Friendly Version
02/15/08Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
First Laboratory Developed Test in the U.S. for Detecting the Mosquito-Borne Infectious Disease CYPRESS, Calif., Feb 15, 2008 /PRNewswire via COMTEX News Network/ -- Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics (NYSE: DGX), today announced the first laboratory developed test in the U.S. for detecting the mosquito-borne chikungunya virus. Commercial availability of the molecular polymerase chain reaction (PCR) test will enable physicians in the U... 
Printer Friendly Version
02/14/08Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on April 18, 2008, to shareholders of record on April 4, 2008. About Quest Diagnostics Quest Diagnostics is the leading provider of diagnostic testing, information and ... 
Printer Friendly Version
01/29/08Quest Diagnostics to Speak at Wachovia Securities 2008 Healthcare Conference
MADISON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Wachovia Securities 2008 Healthcare Conference on Wednesday, January 30, 2008, at the Langham Hotel, Boston, Massachusetts. The Quest Diagnostics presentation is scheduled to begin at 8:00 a.m. Eastern Time. During the conference, the company will reaffirm its 2007 ... 
Printer Friendly Version
01/17/08Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
Reaffirms Previous Guidance for 2007 MADISON, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it will report results for the fourth quarter and year ended December 31, 2007 and provide financial guidance for 2008 on February 21, 2008, instead of the previously scheduled date of January 29. The company is rescheduling its report of f... 
Printer Friendly Version
01/11/08MedPlus to Implement Clinical Portal and Information Exchange for the Brooklyn Health Information Exchange
MADISON, N.J., Jan. 11 /PRNewswire/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has been awarded a contract to implement a clinical portal and information exchange for the Brooklyn Health Information Exchange (BHIX). Organized by Maimonides Medical Center and other healthcare organizations in New York, the BHIX is a not-for-profit corporation that will offer health information exchange services in B... 
Printer Friendly Version
01/07/08Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
MADISON, N.J., Jan 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 11:00 a.m. Eastern Time. The presentation will be webcast ... 
Printer Friendly Version